The move strengthens Tyber Medical’s international presence and adds a range of product options in the MIS bunion, PEEK hammertoe and screw fixation arenas.
Mid-tier companies Orthofix and SeaSpine merged in early January 2023 to become the ninth-largest company in orthopedics.
The combined organization creates the eighth-largest spine company, with a portfolio spanning trauma, orthobiologics and bone growth therapies.
CurveBeam and StraxCorp completed their previously-announced merger. Under the new name CurveBeam AI, the company expands CurveBeam’s point-of-care imaging solutions…
The combined organization creates the eighth-largest spine company, bolstered by a well-balanced portfolio spanning trauma, orthobiologics and bone growth therapies.
CurveBeam AI expands CurveBeam’s financially viable point-of-care imaging solutions into the bone health space
The resulting business will broaden and derisk Bone Therapeutics’ portfolio thata targets a broad array of inflammatory and orthopedic indications.
Through this acquisition, CONMED acquires next-generation bioinductive collagen scaffold technology for application in sports medicine soft tissue healing.
The action is intended to support increased efficiency in the outpatient ambulatory surgery center market for doctors who treat degenerative spine disease.
Spine Innovations, a spin-off from Groupe FH Ortho’s spine activity, specializes in cervical and lumbar disc prostheses.
The addition of CartiHeal will complement the company’s joint preservation technologies and specifically its HA business.
The transaction expands the enabling technologies platform for Enovis’’ reconstructive portfolio with augmented reality surgical guidance.
SNN is partnering with Rods&Cones to provide smart surgery glasses and digital remote assistance to customers, initially in the UK.
ExsoMed, whose products support an intermedullary approach to treat hand fractures, enhances Acumed’s portfolio of upper extremity solutions for simple to complex injuries.
The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the original $315 million.
The move expands its portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System.
Onkos is expanding its musculoskeletal oncology portfolio with the JTS device to treat pediatric bone cancer.
Don't have an account? Register
Forgot your password? Reset
Register for a free account
As a guest member you get access to more articles and webinars every month.
We noticed you used your personal email account. Please enter your company website URL.
Already have an account? Login
We’ll send a recovery link to your email.
I already have an account! Login